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Abstract 
Aim: To evaluate the patient-applied OptrexTM Dry Eye Blink Test against established 
clinical criteria for the diagnosis of dry eye disease and to evaluate its benefit in 
enhancing screening for DED. 
Methods: Eighty-seven participants aged 38 ± 17 years, (44 female) were 
screened for dry eye disease using the Tear Film and Ocular Surface Society (TFOS) 
Dry Eye Workshop II diagnostic criteria.  In addition to symptoms screening with the 
Ocular Surface Disease Index questionnaire (≥13 cut-off for DED), a sign of loss of 
homeostasis of the tear film in the form of a non-invasive tear breakup time (NIBUT) 
<10s (Oculus Keratograph; K5m), an osmolarity reading ≥308mOsm/L or an interocular 
difference in osmolarity of >8 (Tearlab), or ocular surface staining (>5 fluorescein 
corneal spots, >9 lissamine green spots or lid wiper staining [≥2mm length & ≥25% 
width]) was required to confirm a diagnosis of DED. The self-administered Blink Test, 
which requires the participant to observe an image on a computer screen and report 
the length of time (in seconds) that they can refrain from blinking without discomfort, 
was repeated three times. 
Results: Using a cut-off of 10s, the Blink Test demonstrated sensitivity of 66%, 
specificity of 88%, and an area under the curve of 0.77 (p<0.001), in predicting a 
diagnosis of DED according to the TFOS DEWS II criteria. The correlation between the 
Blink Test and NIBUT was r=0.47, p<0.001). When combined with the screening 
questionnaire, the sensitivity and specificity of the Blink Test increased to 71% and 
90% respectively. 
Conclusion: The Blink Test offers health professionals without advanced 
instrumentation, as well as patients, themselves, a rapid method of identifying possible 
DED.  
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Introduction 
“Dry eye disease (DED) is a multifactorial disease of the ocular surface characterized 
by a loss of homeostasis of the tear film, and accompanied by ocular symptoms, in 
which tear film instability and hyperosmolarity, ocular surface inflammation and 
damage, and neurosensory abnormalities play etiological roles”.[1] The Tear Film and 
Ocular Surface Society (TFOS) Dry Eye Workshop (DEWS) II provided this updated 
definition, focusing on the loss of homeostasis in addition to symptoms, as the central 
pathophysiological concept of dry eye disease (DED). Tear film instability is considered 
to be a principal factor in the vicious cycle of disease, perpetuating tear film 
hyperosmolarity and ocular surface inflammation leading to ocular surface damage.[2]  
The prevalence of DED has been estimated to be between 5% and 50%,[3] although 
the presence of signs and symptoms has been a prerequisite of few studies to date 
and none have yet been published conforming to the new global consensus on DED 
diagnosis. Globally, the incidence has been found to be higher in Asian, than in 
Caucasian, populations. DED prevalence increases approximately linearly with age, 
with a steeper rise by decade for clinical signs than for the prevalence of symptoms. 
Sex-related differences become significant only with increasing age.[3]  
DED causes both an economic and social burden on those who suffer with this chronic 
condition.[4] It has been shown that DED can reduce the everyday quality of life of 
those with the disease.[5] Mild to severe DED has been associated with anxiety and 
depression.[6-8] In particular, patients suffering from DED secondary to Sjögren’s 
syndrome reportedly have a high prevalence and severity of depression.[9] 
The prevalence of ocular symptoms related to DED is difficult to quantify, as symptoms 
are not spontaneously reported by many patients unless specifically asked. Hence, 
non-selective use of validated questionnaires such as the Dry Eye Questionnaire 5-
item [10] or Ocular Surface Disease Index (OSDI)[11] can aid in screening for DED. It’s 
also important, through differential diagnosis, to exclude non-dry eye conditions that 
can mimic some of the DED signs and symptoms such as ocular allergy, infection and 
even binocular vision anomalies.[12, 13] Exclusion of such non-dry eye cases, together 
with a positive symptom score, prompts testing to identify whether there is an 
accompanying loss of homeostasis, and this is most often undertaken in a specialist 
clinic due to the time and equipment requirements. Tests recommended by TFOS 
DEWS II for identifying the loss of homeostasis of the tear film are those that evaluate 
non-invasive breakup time (with a cut-off time of <10s deemed to indicate DED), 
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osmolarity (with a value of ≥308mOsm/L or a difference of >8mOsm/L between the two 
eyes), and ocular surface corneal staining (>5 fluorescein spots), conjunctival staining 
(>9 lissamine green spots) or lid wiper epitheliopathy at the inner eyelid margin 
(stained zone width with the combined dyes of ≥25% and length ≥2 mm).[12] If any one 
of these tests identifies a loss of homeostasis then, in conjunction with the previously 
confirmed symptomology, a diagnosis of DED is made.  
Since pharmacists and general practitioners most often lack access to the 
technology/dyes for diagnosing dry eye or monitoring treatment effects, availability of a 
rapid self-assessment test for dry eye could allow non-eyecare practitioners to give 
better advice to patients and make more appropriate referrals for a full diagnosis or 
differential diagnosis.  Raising awareness of possible dry eye in patients themselves, 
might also encourage affected individuals to seek appropriate advice and 
management.  The present investigation thus sought to validate a patient-self-
assessed test (OptrexTM Dry Eye Blink Test) and determine the level of certainty with 
which a diagnosis of DED might be made in the absence of specialist equipment 
against an established diagnosis, according to TFOS DEWS II. 
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Methods 
This study was conducted in accordance with the principles of the Declaration of 
Helsinki and approved by the institutional ethics committees of Aston University, 
Birmingham, United Kingdom and the University of Auckland, Auckland, New Zealand. 
Study participants were recruited from both centres and were enrolled following 
explanation of the procedures and after providing written informed consent. Eighty-
seven adults, ranging in age from 19 to 87 years old (mean age 38±17) (43 males, 44 
females) were enrolled in the study. All subjects were in good general health and were 
able to participate in the test sessions without difficulty. Subjects with any active ocular 
disease or currently using ocular medications were excluded. None of the subjects 
were contact lens wearers. In particular subjects with a range of DED were recruited to 
test the discriminatory ability of the Blink Test. 
 
Room conditions were maintained at a temperature of 20.8 ± 2.1ºC and relative 
humidity of 46.1 ± 9.2%, and subjects spent a minimum of 10 minutes acclimatising to 
the study room conditions before measurements were captured. The participants were 
asked to answer the 5 item DEQ questionnaire which scores eye discomfort and eye 
dryness frequency from 0 (never) to 4 (constantly) and intensity from 0 (never have it) 
to 5 (very intense) along with watery eye frequency. In addition they scored the 12 item 
OSDI questionnaire, which scores experience of 3 ocular symptom questions, 6 visual 
function-related questions and 3 environmental trigger questions during their previous 
week from 0 (none of the time) to 4 (all of the time). The final score is calculated with 
the following formula; 
OSDI = 			
	

			

 
 
DED signs were assessed from the right eyes of subjects only in the following order. 
Non-invasive tear film stability (NIBUT) was assessed objectively with the Keratograph 
5M (Oculus, Wetzlar, Germany) using the infrared light setting, after two non-forceful 
blinks, from automated detection of disruption of a projected mire pattern reflected from 
the tear film surface, during a period of non-blinking.[14, 15] An average of three 
‘average breakup time’ measurements was recorded each time. 
 
The mean values of three consecutive Blink Test measurements were obtained (the 
manufacturer’s instructions does not specify repetition). Test instructions were 
displayed on a 15-inch thin-film-transistor liquid-crystal display digital screen positioned 
at ~40cm from the participant. The patient was requested to make 2 non-forceful 
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blinks, before ceasing blinking, and to press a timer button on the screen when 
discomfort was noted (Figure 1). 
 
Figure 1: The OptrexTM Dry Eye Blink Test (with permission from Reckitt 
Benckiser) 
 
 
Tear film osmolarity was measured at the inferior tear meniscus with an impedance-
based, low volume osmometer (TearLab, San Diego, USA).[16] Daily instrument 
calibration was performed and stability in temperature ensured in accordance with the 
manufacturer’s instructions.[12] Measures were collected non-invasively from each 
eye, and the maximum osmolarity and interocular difference recorded. 
 
Conjunctival damage was evaluated with the aid of lissamine green dye (Green Glo, 
HUB Pharmaceuticals LLC, Rancho Carcamonga, CA, USA). The strip was wet with 
saline and the lissamine green solution instilled at the temporal canthus, after a period 
of 5s to ensure an adequate concentration of lissamine green. Care was taken to avoid 
conjunctival or lid wiper tissue damage. Grading was conducted between 1 to 4 
minutes after instillation (ocular staining score 0: 0-9 dots; 1: 10-32 dots; 2: 33-100 
dots; 3: >100 dots). Corneal damage was evaluated using sodium fluorescein strips. 
The strip was wet with saline solution and the excess shaken off to minimise instillation 
volume. Grading (ocular staining score 0: 0 dots; 1: 1-5 dots; 2: 6-30 dots; 3: >30 
dots)[17] was conducted between 1 and 3 minutes after instillation.[18] Lid wiper 
epitheliopathy was observed after corneal and conjunctival grading, and was graded (0: 
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length <2mm, <25% of the lid wiper; 1: length 2-4mm, 25% - <50% of the lid wiper; 2: 
length 5-9mm, 50% - <75% of the lid wiper; 3: length >10mm, ≥75% of the lid 
wiper)[19] 3 – 6 minutes after instillation of a further drop of lissamine green from a new 
strip by one of three trained researchers.[12] 
 
 
Data analysis 
Statistical analysis was performed using Graph Pad Prism version 6.02 (California, 
USA) and IBM SPSS Statistics version 23 (New York, USA). Due to the Blink Test 
having a maximum duration of 15s, all NIBUT durations >15s were recorded as 15s. 
The distributions of all continuous variables were assessed using the Kolmogorov-
Smirnov normality test, and non-normally distributed measurements (blink test value 
and non-invasive tear film breakup time) underwent logarithmic transformation before 
further analysis. The mean blink test and non-invasive tear film breakup time were 
compared using the paired t-test, variances assessed using the F-test, and Bland-
Altman analysis then performed to determine the level of agreement between the two 
measurements. Correlation analysis of ocular measurements with the blink test value 
was conducted using Spearman’s rank correlation coefficient. A receiver operative 
characteristic (ROC) curve was constructed to assess the diagnostic ability of the Blink 
Test measurements in discriminating whether or not subjects fulfilled the TFOS DEWS 
II dry eye diagnostic test battery. The area under the curve (C-statistic) and diagnostic 
accuracy values at the Youden’s optimal diagnostic cut-off were then calculated. All 
tests were two-tailed and p<0.05, considered significant. 
A sample size of 85 was calculated to significantly power an association of r ≥0.30 
between the Blink Test result, NIBUT and other DED variables.  
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Results 
Of the 87 participants enrolled, 62 (71%) subjects fulfilled the TFOS DEWS II 
diagnostic criteria for DED (Table 1). 
  
Table 1: Demographic, ocular surface, and tear film characteristics of the study 
participants. Data are presented as mean ± SD, median (IQR), or the number of 
participants (% of participants). 
Characteristic Values 
Age (years) 38±17 
Female sex 44 (51%) 
Ethnicity  
   European 38 (44%) 
   East Asian 40 (46%) 
   South Asian 4 (5%) 
   Other 5 (6%) 
TFOS DEWS II dry eye diagnostic criteria met 62 (71%) 
OSDI score 19±16 
DEQ-5 score 9±4 
Tear film osmolarity (mOsm/L) 305±14 
Inter-ocular difference in osmolarity (mOsm/L) 9±7 
Non-invasive tear film breakup time (s) 9.5±7.3 
Optrex Blink Test value (s) 9.8±4.0 
Corneal staining score 0 (0-1) 
Conjunctival staining score 0 (0-1) 
Superior lid wiper epitheliopathy grade 0 (0-0) 
Inferior lid wiper epitheliopathy grade 0 (0-2) 
 
Comparative analysis between the Blink Test and non-invasive tear film stability 
The strength of the association between the Blink Test, as a patient-reported 
'equivalent' to NIBUT, and NIBUT itself, was evaluated. Following logarithmic 
transformation, the mean Blink Test and non-invasive tear film stability measurements 
did not differ significantly (p=0.15). The F-test of variances showed that the Blink Test 
had a narrower distribution than non-invasive tear film breakup time (p<0.001). A 
significant positive correlation was observed between the two measurements (rs=0.47, 
p<0.001). Bland-Altman analysis (Figure 2) showed a mean bias (95% limits of 
agreement) of -0.3 (± 13.5)s. Adjusting the Bland-Altman mean biases to the pre-
transformed equivalents, the blink test values were on average 1.13 (0.36 to 3.55) 
times those of non-invasive tear film stability. 
 
Figure 2: Bland-Altman analysis of difference between non-invasive tear breakup 
time and Blink test. Solid line represent the bias and dotted lines the 95% limits of 
agreement. N=87. 
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Correlation analysis of DED signs and symptoms with the Blink Test  
Correlation analyses of dry eye signs and symptoms with the Blink Test value are 
presented in Table 2. Significant negative correlations with OSDI, DEQ-5, conjunctival 
staining, and inferior lid wiper epitheliopathy were observed (all p<0.05). 
 
Table 2: Correlation analysis of dry eye signs and symptoms with the Blink Test. Data 
are presented as Spearman’s rank correlation coefficients. Asterisks denote statistically 
significant values (p<0.05). 
Ocular measurement 
Correlation with 
Blink Test value 
Coefficient p 
OSDI Score −0.290 0.006* 
DEQ-5 Score −0.364 0.004* 
Tear film osmolarity (higher value) (mOsm/L) −0.066 0.55 
Interocular difference in osmolarity (mOsm/L) −0.010 0.93 
Corneal staining score  −0.163 0.13 
Conjunctival staining score −0.237 0.03* 
Superior lid wiper epitheliopathy grade 0.018 0.87 
Inferior lid wiper epitheliopathy grade −0.251 0.02* 
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Diagnostic ability of the Blink Test 
The Blink Test was a moderately strong indicator of a DED diagnosis according to 
TFOS DEWS II (Table 3; Figure 3). The average of three repeats of the Blink Test was 
more sensitive than a single measure and resulted in a greater area under the receiver 
operating curve.   
 
Table 3: Diagnostic accuracy indicators of the Blink Test (single measure or average of 
3 values) versus the TFOS DEWS II diagnostic criteria or signs of homeostasis.  
 
 
TFOS DEWS II diagnostic 
criteria 
TFOS DEWS II signs of 
homeostasis 
Diagnostic accuracy value Blink Test (averaged value) 
Blink Test 
(single value) 
Blink Test 
(averaged 
value) 
Blink Test 
(single value) 
C-statistic, 95% CI 0.77 (0.68 to 0.87) 
0.70 (0.59 to 
0.82) 
0.81 (0.71 to 
0.91) 
0.70  (0.55 to 
0.85) 
C-statistic p-value <0.001* 0.003* 0.001* 0.04* 
Youden’s optimal diagnostic 
cut-off 
≤10 <8 ≤11 ≤8 
Sensitivity, 95% CI 66% (53% to 78%) 
53% (40% to 
66%) 
71% (60% to 
81%) 
52% (40% to 
63%) 
Specificity, 95% CI 88% (69% to 97%) 
88% (69% to 
98%) 
90% (56% to 
100%) 
90% (56% to 
100%) 
Positive predictive ability, 95% 
CI 
93% (82% to 
98%) 
92% (79% to 
97%) 
98% (90% to 
100%) 
98% (86% to 
100%) 
Negative predictive ability, 
95% CI 
51% (42% to 
60%) 
43% (36% to 
51%) 
29% (21% to 
38%) 
20% (15% to 
25%) 
Positive likelihood ratio, 95% 
CI 
5.51 (1.88 to 
16.17) 
4.44 (1.50 to 
13.15) 
7.14 (1.11 to 
46.10) 
5.19 (0.80 to 
33.77) 
Negative likelihood ratio, 95% 
CI 
0.38 (0.26 to 
0.56) 
0.53 (0.39 to 
0.72) 
0.32 (0.21 to 
0.48) 
0.53 (0.39 to 
0.73) 
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Figure 3: Receiver operative characteristic curves assessing the diagnostic ability of 
the Blink Test in discriminating whether subjects fulfilled the (a) TFOS DEWS II dry eye 
diagnostic test battery or (b) homeostasis marker signs. 
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Discussion 
The OptrexTM Dry Eye Blink Test is advertised as a rapid online test to indicate whether 
an individual might have dry eye. Like the clinical tear breakup test, it reflects the 
stability of the tears, however, in this test the time taken for the eyes to sense ocular 
discomfort is the measure for dry eye rather than the clinical assessment of when the 
tear film first ‘breaks’. However, the diagnostic potential of the self-reported Blink Test 
approach has not been investigated previously. In order to test the validity of this 
approach, the current study examined how well the Blink Test performed against the 
TFOS DEWS II diagnostic criteria for dry eye disease.  
 
The results showed that the mean blink test and NIBUT results were not significantly 
different. The Blink Test has a narrower distribution than NIBUT, even when NIBUT is 
capped at 15s, hence in its current form, the disagreement beyond this point will 
increase. Bland-Altman analysis showed fair levels of clinical agreement between the 
two tests, however the limits of agreement were moderately wide. As expected, there 
was also a positive correlation between the tests, with the blink time increasing as 
NIBUT increased. Tear film breakup is associated with increasing ocular discomfort 
and this is well documented in the literature.[20, 21] It is thought that tear breakup 
during the blink-interval results in a transient, localised, increase in tear osmolarity, 
which in turn stimulates the corneal nociceptors, driving the blink reflex to replenish the 
tear film.[21] If the breakup of tears on the ocular surface led directly to a rapid loss of 
comfort, it would be expected that the correlation between NIBUT and the Blink Test 
would have been greater than moderate. Hence the results suggest that other 
individual factors, such as the patient’s tolerance to pain, the area of breakup and 
osmolarity levels, affect when patients report discomfort. A more frequent blink rate has 
been associated with a shorter NIBUT and this may be a compensatory mechanism to 
mitigate the effects of reduced tear stability.[22] It is known that blink rate diminishes 
during tasks involving concentration, which may explain why ocular discomfort is 
commonly experienced by computer users.[23] The blink test, being an online tool, is a 
relevant tool for such individuals, amongst whom evaporative dry eye is a rising issue. 
Although it does not simulate a truly natural state, it may reflect the typical stresses on 
the tear film that occur during the day. The Blink Test also demonstrated a significant 
negative correlation with conjunctival staining levels such that longer Blink Test time 
were associated with higher symptomology scores and a lower level of ocular surface 
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staining. While other ocular measures of dry eye showed similarly negative trends with 
higher Blink Test scores, these were not statistically significant.  
Poor correlation is not infrequently reported between objective clinical test outcomes 
and symptom severity.[24] This may be due partly to a degree of compensation by 
blinking more frequently which would serve to reduce the time the tear film needs to 
maintain its interblink homeostasis. The instantaneous and quantitative Blink Test has 
the potential to be a more reliable indicator of dry eye risk, by overcoming issues 
associated with inaccurate patient recall of discomfort symptoms over the previous 
month, as posed by typical dry eye questionnaires. According to the Blink Test 
instructions, contact lenses do not need to be removed before taking the test, widening 
its applicability to a broader patient group. The validity of the test in this demographic 
was not addressed in the present study, but requires independent evaluation. Contact 
lenses may act as a partial barrier to corneal sensation,[20] and therefore their wear 
during the test might be expected to overestimate the Blink Test time (giving a false 
negative result). 
Test sensitivity is a measure of how well a test correctly identifies those with disease, 
whereas specificity evaluates how well a test can correctly identify those without 
disease. A trade-off typically exists between the two with the precise values for each 
influenced by the selected cut-off value for a positive diagnosis. Maximal sensitivity and 
specificity for the Blink Test was achieved with a cut-off of ≤10s. This offered a 
sensitivity and specificity of 66% and 88%, respectively. The ROC curve (Figure 3) 
shows this graphically, with the area under the curve demonstrating high diagnostic 
ability (AUC=0.77, P<0.001). Interestingly the optimal cut-off for the Blink Test aligned 
closely with that reported by TFOS DEWS II, for NIBUT.[12] 
 
As questionnaires are rapid and simple to administer outside a clinical setting, the 
sensitivity and specificity of the Blink Test as a surrogate for detecting a loss of 
homeostasis as classified by TFOS DEWS II,[12] was also assessed. Screening out 
non-symptomatic individuals first, demonstrated improved discrimination (71% 
sensitivity, 90% specificity and an AUC of 0.81), compared with the Blink Test alone. It 
was further examined whether a single assessment of the Blink test would be adequate 
to save testing time, however, it was clearly demonstrated that, like NIBUT 
measurement in clinical practice, an average of three repeats of the Blink Test 
improves diagnostic sensitivity and therefore should be recommended. 
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All procedures on a participant were carried out by a single examiner, therefore 
investigator-masking was not possible. However, all were objective or participant 
completed so operator bias in the results is unlikely. Ocular surface grading was 
completed subsequent to the Blink Test and without reference to the other clinical 
findings, and so was effectively masked. As the Blink Test is designed for completion in 
non-clinical settings, the working distance used was only approximately 40cm and the 
gaze angle will have differed depending on patient height and sitting stature. Screen 
illumination and screen size could also affect the blink rate and induce reflex tearing so 
are other factors that could affect the result. However, despite this, the Blink Test was 
demonstrated to be a useful indicator of the presence of DED that can be easily 
applied in non-specialist eye-care settings to aid in the identification and management 
monitoring of this chronic, debilitating disease, with a view to improving patient 
outcomes. 
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